ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1960

Pleiotropy of Genetic Predisposition to Rheumatoid Arthritis Increases the Risk for Autoimmune Disease

Vivian Kawai1, Mingjian Shi 1, Qiping Feng 2, Cecilia Chung 1, Ge Liu 2, Nancy Cox 2, Dan Roden 2, C. Michael Stein 1 and Jonathan Mosley 2, 1Vanderbilt University Medical Center, Nashville, TN, 2Vanderbilt University Medical Center, Nashville

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: genetic architecture and risk, genetics, Rheumatoid arthritis (RA), risk assessment

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 12, 2019

Title: Genetics, Genomics & Proteomics Poster

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid arthritis (RA) is a chronic autoimmune disorder that is associated with increased risk of cardiovascular disease, cardiometabolic disorders, and autoimmune disease. Thus, we examined the hypothesis that genetic predisposition to RA increases the risk for cardiovascular disease, cardiometabolic disorders, and other autoimmune disorders.

Methods: To test this hypothesis, we selected 102 independent SNPs (R2< 0.10) that were significantly associated with RA (P< 5×10-8) in the largest transethnic meta-analysis published. In the Vanderbilt DNA biobank (BioVU), ninety-five SNPs had a call rate ≥ 95% and were used to construct a weighted genetic risk score (wGRS) for RA to: 1) test its association with 9 cardiometabolic disorders (Table 1) and 2) perform a global phenome wide association study (PheWAS) examining the relationship between the wGRS and all phenotypes present in 29,892 Caucasian patients adjusting for median age in the electronic health record, sex, and 5 principal components. A P-value ≤ 0.006 was considered significant for the 9 selected cardiometabolic diseases and a false discovery rate (FDR) < 0.1 was used in the global PheWAS. In addition, a set of independent RA-associated SNPs (R2< 0.05) was used to perform a two-sample inverse-variance weighted regression (IVWR) meta-analysis using publicly available summary statistics for the 9 cardiometabolic phenotypes of interest (or proxies). Egger regression was performed to test horizontal pleiotropy with phenotypes in which the IVWR analysis was significant.

Results: Among the 9 cardiometabolic phenotypes selected, the wGRS for RA was significantly associated with type I diabetes (T1D) (P=9.82×10-4, Table 1). In the global PheWAS, the wGRS was associated with increased risk for several autoimmune phenotypes including RA (OR=1.41, P=1.54×10-27), thyroiditis, systemic sclerosis, and T1D phenotypes, and with protection against multiple sclerosis and demyelinating disorders (Fig. 1). In the IVWR analysis, RA was significantly associated with type 2 diabetes (T2D) (P=4.04×10-4, Table1), but the association was abrogated when an RA SNP in the HLA region (rs9268839) was excluded from the analysis (P=0.133). T1D was also significantly associated with RA in the IVWR analysis (P=1.93×10-10, Table 1, Fig. 2) with the Egger intercept term suggesting horizontal pleiotropy (P< 0.001). When rs2476601 (an RA SNP in PTPN22) was excluded, the IVWR analysis remained significant (P=1×10-4) and the intercept term in the Egger regression no longer showed evidence of horizontal pleiotropy (P=0.611).

Conclusion: We found evidence suggesting pleiotropy between genetic predisposition for RA and several other autoimmune disorders including T1D. The IVWR analysis showed that genetic predisposition to RA was associated with increased risk of T1D, even after the exclusion of a common variant in PTPN22 known to be associated with different autoimmune disorders.


Table_1_RA

Table 1: Association of the wGRS for RA with 9 clinical diagnoses -or proxies- using a PheWAS and IVWR approach


RA_Fig_1

Figure 1: Clinical diagnoses associated with wGRS for RA


Rplots

Figure 2: Scatter plot comparing the association between the genetic predisposition for RA and the risk for T1D for SNPs significantly associated with RA in Caucasians.


Disclosure: V. Kawai, NIH K23GM117395, 2, NIH NIGMS K23GM117395, 2, NIH/NIGMS K23GM117395, 2, NIH, 2, NIH, 2; M. Shi, None; Q. Feng, None; C. Chung, Lupus Research Alliance, 2, NCATS/NIH CTSA grant ULTR000445, 2, Rheumatology Research Foundation, 2, Veterans Health Administration CDA, 2; G. Liu, None; N. Cox, None; D. Roden, American Heart Association (18SFRN342300)89, 2, American Heart Association (18SFRN342300)89, 2; C. Stein, None; J. Mosley, None.

To cite this abstract in AMA style:

Kawai V, Shi M, Feng Q, Chung C, Liu G, Cox N, Roden D, Stein C, Mosley J. Pleiotropy of Genetic Predisposition to Rheumatoid Arthritis Increases the Risk for Autoimmune Disease [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/pleiotropy-of-genetic-predisposition-to-rheumatoid-arthritis-increases-the-risk-for-autoimmune-disease/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pleiotropy-of-genetic-predisposition-to-rheumatoid-arthritis-increases-the-risk-for-autoimmune-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology